Glucocorticoid dexamethasone down-regulates basal and vitamin D3 induced cathelicidin expression in human monocytes and bronchial epithelial cell line
Highlights • Glucocorticoid (GC) dexamethasone down-regulates basal mRNA expression of the antimicrobial peptide genes CAMP (cathelicidin antimicrobial peptide), DEFB1 (human beta defensin 1), LZY (lysozyme) and SLPI (secretory leukocyte proteinase inhibitor 1) in THP-1 monocytes. • Dexamethasone re...
Gespeichert in:
Veröffentlicht in: | Immunobiology (1979) 2016-02, Vol.221 (2), p.245-252 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Highlights • Glucocorticoid (GC) dexamethasone down-regulates basal mRNA expression of the antimicrobial peptide genes CAMP (cathelicidin antimicrobial peptide), DEFB1 (human beta defensin 1), LZY (lysozyme) and SLPI (secretory leukocyte proteinase inhibitor 1) in THP-1 monocytes. • Dexamethasone reduces vitamin D3 enhanced human cathelicidin ( CAMP ) gene expression in THP-1 monocytes, primary human monocytes and in the bronchial epithelial cell line BCi NS 1.1. • The Glucocorticoid receptor inhibitor RU486 prevents dexamethasone mediated inhibition of CAMP gene. |
---|---|
ISSN: | 0171-2985 1878-3279 1878-3279 |
DOI: | 10.1016/j.imbio.2015.09.001 |